---
document_datetime: 2023-09-21 20:59:18
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/integrilin-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: integrilin-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 11.5206039
conversion_datetime: 2025-12-21 19:11:37.207766
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Integrilin

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0088               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 24/09/2021                          |                                             | Labelling and PL                 |           |
| IB/0087/G            | This was an application for a group of variations.                                               | 03/08/2021                          | n/a                                         |                                  |           |

1 Notifications are issued for type I  variations and Article 61(3) notifications (unless part of a group including a type II  variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II,  labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC  (Summary  of Product Characteristics), Annex II,  Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    | the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF A.7 - Administrative change - Deletion of manufacturing sites      |            |            |                                  |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IA/0086            | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                           | 07/05/2021 | n/a        |                                  |                                   |
| IA/0085            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                          | 10/02/2021 | 19/10/2021 | Annex II and PL                  |                                   |
| IAIN/0084          | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 15/01/2021 | n/a        |                                  |                                   |
| IB/0083            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                         | 08/09/2020 | 19/10/2021 | SmPC, Annex II, Labelling and PL |                                   |
| PSUSA/1246/ 202001 | Periodic Safety Update EU Single assessment - eptifibatide                                                                                                                                                                             | 04/09/2020 | n/a        |                                  | PRAC Recommendation - maintenance |
| IA/0081            | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits                                                                                        | 20/12/2019 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0080          | B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing                                                                                                       | 25/03/2019   | 09/03/2020   | Annex II and PL            |                                   |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------|-----------------------------------|
| T/0079             | Transfer of Marketing Authorisation                                                                                                                                                                                                         | 12/10/2018   | 29/10/2018   | SmPC, Labelling and PL     |                                   |
| IB/0078            | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                      | 25/07/2018   | n/a          |                            |                                   |
| IA/0077            | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material,reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 14/11/2017   | n/a          |                            |                                   |
| PSUSA/1246/ 201701 | Periodic Safety Update EU Single assessment - eptifibatide                                                                                                                                                                                  | 01/09/2017   | n/a          |                            | PRAC Recommendation - maintenance |
| IB/0075            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                              | 12/04/2017   | 16/03/2018   | Annex II, Labelling and PL |                                   |
| IB/0073            | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originallyapproved batch size                                                                                   | 21/12/2015   | n/a          |                            |                                   |
| N/0074             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                            | 24/11/2015   | 12/05/2016   | PL                         |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0072   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 12/11/2015   | n/a        |                                  |                                   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------|
| IB/0071   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 19/05/2015   | 12/05/2016 | SmPC, Annex II, Labelling and PL |                                   |
| PSUV/0070 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 11/09/2014   | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0069   | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 20/12/2013   | n/a        |                                  |                                   |
| IB/0068/G | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an | 20/12/2013   | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0067/G   | a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate   | 16/12/2013   | n/a        |                        | This was an application for   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------------------|
| N/0066      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                              | 07/11/2013   | 23/04/2014 | PL                     |                               |
| IG/0279     | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                    | 18/04/2013   | 23/04/2014 | SmPC, Labelling and PL |                               |
| IG/0275     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                | 15/03/2013   | n/a        |                        |                               |
| N/0062      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                              | 25/04/2012   | 23/04/2014 | Labelling and PL       |                               |
| IG/0150/G   | This was an application for a group of variations. C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV                                                                                                                                                                                                                                                                                                                           | 05/04/2012   | n/a        |                        |                               |

<div style=\"page-break-after: always\"></div>

|           | C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |            |             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| II/0056   | C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilancedata                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 16/02/2012 | 21/03/2012 | SmPC and PL |
| IB/0055/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 31/01/2012 | n/a        |             |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |     |                                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------|
| IB/0054/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, ifan alternative test procedure is already authorised B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or | 31/01/2012 | n/a | starting material/reagent/intermediate |

<div style=\"page-break-after: always\"></div>

|         | changes to an approved test procedure                                                                                                                                                                                                                   |            |            |             |                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------|
| IA/0061 | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                     | 14/01/2012 | n/a        |             |                                                                                                                 |
| IA/0060 | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                     | 14/01/2012 | n/a        |             |                                                                                                                 |
| IA/0059 | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                     | 14/01/2012 | n/a        |             |                                                                                                                 |
| IB/0053 | C.I.3.a - Implementation of change(s) requested following the assessment ofan USR, class labelling,a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted bythe MAH | 06/01/2012 | 21/03/2012 | SmPC and PL |                                                                                                                 |
| IA/0058 | A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the AS, starting material,reagent or intermediate used in the manufacture of the AS                                                                    | 22/12/2011 | n/a        |             |                                                                                                                 |
| IA/0057 | B.I.c.3.b - Change in test procedure for the immediate packaging of the AS - Other changes to a test procedure (including replacement or addition)                                                                                                      | 16/12/2011 | n/a        |             |                                                                                                                 |
| II/0051 | Update of Summary of Product Characteristics                                                                                                                                                                                                            | 23/06/2011 | 27/07/2011 | SmPC        | Update of Summary of Product Characteristics to update the section 4.4 Special warnings and precautions for use |

<div style=\"page-break-after: always\"></div>

|           | C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilancedata                                                                                                                                                                                                                                                                                                                    |            |            |                       | with regards to potential for immune related thrombocytopenia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0049   | C.I.4 - Variations related to significant modifications of the Summary of Product Characteristics due in particular to new quality, pre-clinical, clinical or pharmacovigilance data. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilancedata                                                                                                                              | 17/03/2011 | 14/04/2011 | SmPC, Annex II and PL | This variation seeks to update the Summary of Product Characteristics and Package Leaflet with data from the EARLY-ACS study. Sections 4.4 of the SmPC will be amended to include that early administration of eptifibatide may be associated with an increased risk of bleeding and Section 5.1 will include the EARLY-ACS data in support of this warning. In addition, the MAH took the opportunityto align the SmPC with the new QRD template version 7.3 (addition of headings in sections 4.2, 4.6 and 5.1); amend EMEA to EMA in website address and removal of EMEA acronym in Patient Information leaflet (PIL); update the contact phone number for Cyprus in the PIL; and in annex IIB delete the condition that \"The MAH will continue to provide Periodic |
| IG/0034/G | This was an application for a group of variations. C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons | 06/01/2011 | n/a        | Annex II              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

|         | or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.g - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the site undertaking pharmacovigilance activities C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system   |            |            |          |                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0050 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 18/05/2010 | n/a        |          |                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0047 | Update of the Detailed Description of the Pharmacovigilance System (DDPS) including change of the Qualified Person for Pharmacovigilance (QPPV). Consequently, Annex II has been updated with the new version number. Changes to QPPV Update of DDPS (Pharmacovigilance)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 17/12/2009 | 20/01/2010 | Annex II | The DDPS has been updated (version 7.2) to reflect the change of the QPPV as well as to notify other changes to the DDPS performed since the last approved version. Consequently,Annex II has been updated using the standard text including the new version number of the agreed DDPS. The CHMP considers that the Pharmacovigilance System as described by the MAH fulfils the requirements. |

<div style=\"page-break-after: always\"></div>

| IA/0048   | IA_09_Deletion of manufacturing site                                                                                                                                                                                                                                                                                                                                           | 05/11/2009   | n/a        | Annex II and PL        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0046   | Update of Summary of Product Characteristics (sections 2, 4.1, 4.2, 4.3, 4.4, 4.5, 4.7, 4.8 and 4.9, 5.1, 6.2, 6.4 and 6.6), Labelling and Package Leaflet following a revision to the Integrilin Product Information following QRD comments during the renewal procedure. Update of Summary of Product Characteristics, Labelling and Package Leaflet                         | 24/09/2009   | 28/10/2009 | SmPC, Labelling and PL | The MAH submit this variation to update the Summary of Product Characteristics, Labelling and Package Leaflet following a revision to the Integrilin Product Information following QRD comments during the renewal procedure.                                                                                                                                                                                                                                       |
| R/0044    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                        | 23/04/2009   | 01/07/2009 | SmPC and PL            | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance, the CHMP is of the opinion that the quality, safety and efficacy of this medicinal product continues to be adequatelyand sufficientlydemonstrated and therefore considered that the benefit risk profile of Integrilin continues to be favourable. The CHMP was also of the opinion that the renewal can be granted with unlimited validity. |
| II/0045   | Update of the Detailed Description of the Pharmacovigilance System (DDPS) in order to include the change of the Qualified Person for Pharmacovigilance (QPPV). In addition, the Marketing Authorisation Holder (MAH) took the opportunityto notify other minor changes to the DDPS performed since the last approved version. Consequently,Annex II has been updated using the | 19/02/2009   | 07/04/2009 | Annex II               | The Detailed Description of the Pharmacovigilance System has been updated (Version 6.2, November 2008) to reflect the change of the Qualified Person for Pharmacovigilance (QPPV) as well as to notify other changes to the DDPS performed since the last approved version. Consequently, Annex II has been updated using the standard text including the new version number of the agreed DDPS.                                                                    |

<div style=\"page-break-after: always\"></div>

|         | standard text including the new version number of the agreed DDPS. Changes to QPPV Update of DDPS (Pharmacovigilance)                   |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0043 | IB_13_b_Change in test proc. for active substance - other changes (replacement/addition)                                                | 16/12/2008 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0042 | Quality changes                                                                                                                         | 30/05/2008 | 25/06/2008 |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IA/0041 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                       | 08/11/2007 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IA/0040 | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                      | 31/07/2007 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0037 | Change(s) to the manufacturing process for the active substance                                                                         | 21/06/2007 | 25/06/2007 |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0039 | Update of Summary of Product Characteristics, Labelling and Package Leaflet. Update of Summary of Product Characteristics and Labelling | 24/01/2007 | 01/03/2007 | SmPC, Labelling and PL | The MAH has applied to amend the posologyfor eptifibatide in patients with impaired renal function,based on the results of a controlled pharmacokinetic/pharmacodynamic study in patients with varying levels of renal function and post-hoc analyses of controlled clinical trials.By reducing the standard infusion dose of eptifibatide from 2.0 µg/kg/min to 1.0 µg/kg/min in patients with moderate renal impairment (i.e. CrCl 30-50 ml/min), appropriate therapeutic exposures to eptifibatide were achieved, while maintaining the efficacyas measured by inhibition of platelet aggregation.Reviewof clinical trial safetydata |

<div style=\"page-break-after: always\"></div>

|         |                                                                                |            |            |                        | related to bleeding showed that patients with moderate renal impairment who received reduced eptifibatide dose had a lower risk of bleeding. This recommendation and posologyin patients with moderate renal impairment has been added in section 4.2 of the SPC and the current contraindication in patients with severe renal impairment in section 4.3 has been clarified accordingly. Further information on the pharmacokinetic properties of eptifibatide in patients with moderate to severe renal insufficiencyhas been added to section 5.2 of the SPC. A letter to inform healthcare professionals of the changes with the updated SPC has been sent following the adoption of this opinion by the CHMP.   |
|---------|--------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0038 | Change(s) to the test method(s) and/or specifications for the finished product | 21/09/2006 | 27/09/2006 |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IB/0036 | IB_17_a_Change in re-test period of the active substance                       | 26/04/2006 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| II/0034 | Update of Summary of Product Characteristics, Labelling and Package Leaflet    | 13/10/2005 | 17/11/2005 | SmPC, Labelling and PL | Inclusion of a new adverse event, pulmonaryhaemorrhage, in the post-marketing section of 4.8 \"Undesirable effects\" in the SPC.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IA/0035 | IA_09_Deletion of manufacturing site                                           | 07/10/2005 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| II/0033 | Update of or change(s) to the pharmaceutical documentation                     | 15/09/2005 | 23/09/2005 |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

| II/0032   | Update of or change(s) to the pharmaceutical documentation                                       | 27/07/2005   | 03/08/2005   |                                  |                                                                 |
|-----------|--------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-----------------------------------------------------------------|
| IA/0031   | IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site                       | 09/12/2004   | n/a          |                                  |                                                                 |
| T/0030    | Transfer of Marketing Authorisation                                                              | 18/10/2004   | 06/12/2004   | SmPC, Labelling and PL           | Transfer of MAH from Schering-Plough Europe to Glaxo Group Ltd. |
| IA/0029   | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing | 05/10/2004   | n/a          | Annex II and PL                  |                                                                 |
| IA/0028   | IA_07_a_Replacement/add.of manufacturing site: Secondary packaging site                          | 05/10/2004   | n/a          |                                  |                                                                 |
| R/0025    | Renewal of the marketing authorisation.                                                          | 23/06/2004   | 02/09/2004   | SmPC, Annex II, Labelling and PL |                                                                 |
| II/0026   | Quality changes                                                                                  | 29/07/2004   | 29/07/2004   |                                  |                                                                 |
| N/0027    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 19/05/2004   | n/a          | PL                               |                                                                 |
| II/0024   | Update of Summary of Product Characteristics and Package Leaflet                                 | 17/12/2003   | 23/02/2004   | SmPC and PL                      |                                                                 |
| I/0023    | 20a_Extension of shelf-life or retest period of the active substance                             | 10/09/2003   | 18/09/2003   |                                  |                                                                 |
| I/0022    | 12_Minor change of manufacturing process of the                                                  | 15/04/2003   | 28/04/2003   |                                  |                                                                 |

<div style=\"page-break-after: always\"></div>

|         | active substance                                                                                                                               |            |            |                        |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| N/0021  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                               | 13/02/2003 | 24/03/2003 | PL                     |
| II/0018 | Update of Summary of Product Characteristics and Package Leaflet                                                                               | 27/06/2002 | 03/10/2002 | SmPC and PL            |
| I/0019  | 15_Minor changes in manufacture of the medicinal product                                                                                       | 12/08/2002 | 05/09/2002 |                        |
| II/0017 | Update of Summary of Product Characteristics and Package Leaflet                                                                               | 13/12/2001 | 19/04/2002 | SmPC, Labelling and PL |
| II/0012 | Change(s) to the manufacturing process for the active substance Change(s) to the test method(s) and/or specifications for the active substance | 17/01/2002 | 07/02/2002 |                        |
| II/0016 | Change(s) to shelf-life or storage conditions                                                                                                  | 18/10/2001 | 17/12/2001 |                        |
| I/0015  | 24_Change in test procedure of active substance                                                                                                | 09/08/2001 | n/a        |                        |
| I/0014  | 24_Change in test procedure of active substance                                                                                                | 09/08/2001 | n/a        |                        |
| I/0013  | 24_Change in test procedure of active substance                                                                                                | 09/08/2001 | n/a        |                        |
| I/0007  | 15_Minor changes in manufacture of the medicinal product 16_Change in the batch size of finished product                                       | 27/07/2000 | n/a        |                        |

<div style=\"page-break-after: always\"></div>

| I/0010   | 24_Change in test procedure of active substance                  | 27/06/2000   | 06/07/2000   |
|----------|------------------------------------------------------------------|--------------|--------------|
| I/0009   | 24_Change in test procedure of active substance                  | 27/06/2000   | 06/07/2000   |
| I/0008   | 15_Minor changes in manufacture of the medicinal product         | 27/06/2000   | 06/07/2000   |
| I/0006   | 14_Change in specifications of active substance                  | 07/09/1999   | 22/09/1999   |
| I/0005   | 14_Change in specifications of active substance                  | 07/09/1999   | 22/09/1999   |
| I/0004   | 12_Minor change of manufacturing process of the active substance | 07/09/1999   | 22/09/1999   |
| I/0003   | 12_Minor change of manufacturing process of the active substance | 07/09/1999   | 22/09/1999   |
| I/0002   | 12_Minor change of manufacturing process of the active substance | 07/09/1999   | 22/09/1999   |
| I/0001   | 13_Batch size of active substance                                | 07/09/1999   | 22/09/1999   |